rs143991107

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001367721.1(CASK):​c.1794C>T​(p.Asn598Asn) variant causes a synonymous change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000602 in 1,206,876 control chromosomes in the GnomAD database, including 2 homozygotes. There are 271 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00069 ( 0 hom., 24 hem., cov: 23)
Exomes 𝑓: 0.00059 ( 2 hom. 247 hem. )

Consequence

CASK
NM_001367721.1 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 7.56

Publications

0 publications found
Variant links:
Genes affected
CASK (HGNC:1497): (calcium/calmodulin dependent serine protein kinase) This gene encodes a calcium/calmodulin-dependent serine protein kinase. The encoded protein is a MAGUK (membrane-associated guanylate kinase) protein family member. These proteins are scaffold proteins and the encoded protein is located at synapses in the brain. Mutations in this gene are associated with FG syndrome 4, intellectual disability and microcephaly with pontine and cerebellar hypoplasia, and a form of X-linked intellectual disability. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
CASK Gene-Disease associations (from GenCC):
  • FG syndrome 4
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • syndromic X-linked intellectual disability Najm type
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • X-linked syndromic intellectual disability
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant X-41557044-G-A is Benign according to our data. Variant chrX-41557044-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 94375.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000688 (77/111956) while in subpopulation NFE AF = 0.000508 (27/53193). AF 95% confidence interval is 0.000358. There are 0 homozygotes in GnomAd4. There are 24 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High AC in GnomAd4 at 77 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CASKNM_001367721.1 linkc.1794C>T p.Asn598Asn synonymous_variant Exon 19 of 27 ENST00000378163.7 NP_001354650.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CASKENST00000378163.7 linkc.1794C>T p.Asn598Asn synonymous_variant Exon 19 of 27 5 NM_001367721.1 ENSP00000367405.1

Frequencies

GnomAD3 genomes
AF:
0.000688
AC:
77
AN:
111901
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000952
Gnomad ASJ
AF:
0.00452
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00612
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000508
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000993
AC:
182
AN:
183279
AF XY:
0.000944
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00548
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00594
Gnomad NFE exome
AF:
0.000477
Gnomad OTH exome
AF:
0.00155
GnomAD4 exome
AF:
0.000593
AC:
649
AN:
1094920
Hom.:
2
Cov.:
28
AF XY:
0.000685
AC XY:
247
AN XY:
360448
show subpopulations
African (AFR)
AF:
0.0000380
AC:
1
AN:
26332
American (AMR)
AF:
0.00
AC:
0
AN:
35206
Ashkenazi Jewish (ASJ)
AF:
0.00573
AC:
111
AN:
19368
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54089
European-Finnish (FIN)
AF:
0.00656
AC:
266
AN:
40522
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4124
European-Non Finnish (NFE)
AF:
0.000287
AC:
241
AN:
839132
Other (OTH)
AF:
0.000653
AC:
30
AN:
45969
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
20
40
61
81
101
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000688
AC:
77
AN:
111956
Hom.:
0
Cov.:
23
AF XY:
0.000703
AC XY:
24
AN XY:
34118
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30879
American (AMR)
AF:
0.0000951
AC:
1
AN:
10517
Ashkenazi Jewish (ASJ)
AF:
0.00452
AC:
12
AN:
2654
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3570
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2673
European-Finnish (FIN)
AF:
0.00612
AC:
37
AN:
6042
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
216
European-Non Finnish (NFE)
AF:
0.000508
AC:
27
AN:
53193
Other (OTH)
AF:
0.00
AC:
0
AN:
1527
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00127
Hom.:
9
Bravo
AF:
0.000310
EpiCase
AF:
0.000218
EpiControl
AF:
0.000415

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Jan 19, 2016
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jun 30, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:1
Aug 28, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

CASK-related disorder Benign:1
Feb 23, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Intellectual disability, CASK-related, X-linked Benign:1
Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.47
CADD
Benign
10
DANN
Benign
0.67
PhyloP100
7.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143991107; hg19: chrX-41416297; API